← Back to headlines
SHINE Technologies Gains EU CMA for Ilumira Lu-177
SHINE Technologies has received the EU Certificate of Medicinal Product (CMA) for its Ilumira Lu-177 radioisotope, marking a significant regulatory approval.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Metro Manila Workers to Receive First Tranche of Wage Hike on July 25
just now
Philippine Mining Development Corporation Praises 'Big Brother-Small Brother' Initiative
just now
Nigerian President Tinubu Orders Stricter Engineering Regulations
just now